Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab

Orbit. 2024 Dec 18:1. doi: 10.1080/01676830.2024.2439333. Online ahead of print.

Authors

James O Robbins¹, Kourtney H Houser², Christopher R Dermarkarian¹

Affiliations

¹ Department of Oculofacial Plastic and Orbital Surgery, Duke Eye Center, Durham, North Carolina, USA.
² Department of Cornea and External Disease, Duke Eye Center, Durham, North Carolina, USA.

PMID: 39693044
DOI: 10.1080/01676830.2024.2439333

No abstract available

Keywords: Cemiplimab; exenteration; neoadjuvant therapy; ocular surface squamous neoplasia; squamous cell carcinoma.